Analysis

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis

Recursion Pharmaceuticals, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to RXRX.

websiteRXRX/analysis/RXRX

Recursion Pharmaceuticals, Inc.

Recursion Pharmaceuticals, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to RXRX.

Stock profile

Ticker

RXRX

Asset type

Stock

Market cap

$1.71B

Sector

Health Technology

Industry

Biotechnology

Currency

USD

Ticker listings

Recursion Pharmaceuticals, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • RXRX primary listing
  • A3CM1C
  • 8RL

Latest Recursion Pharmaceuticals, Inc. news

Recursion Reports First Quarter Financial Results and Provides Business Update

Multiple milestones achieved or on track across wholly owned and partnered programs REC-1245 (RBM39 degrader): Early clinical data in solid tumors demonstrate a well-tolerated s...

Recursion Announces Board Transition

Salt Lake City, UT, April 30, 2026 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today anno...

Recursion to Report First Quarter 2026 Business Updates and Financial Results on May 6

Company to host public Earnings Call on May 6 at 8:00 am ET / 6:00 am MT / 1:00 pm BST Salt Lake City, UT, April 29, 2026 (GLOBE NEWSWIRE) -- Recursion

Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform

NEW YORK and SALT LAKE CITY, March 31, 2026 (GLOBE NEWSWIRE) -- Citeline, a leader in clinical solutions for the life sciences industry, today announced an expanded strategic pa...

Recursion Announces Vicki Goodman, M.D., as Incoming Chief Medical Officer

Salt Lake City, UT, March 25, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically

Research sections

Valuation

Review valuation context for Recursion Pharmaceuticals, Inc..

Future growth

Review future growth context for Recursion Pharmaceuticals, Inc..

Past performance

Review past performance context for Recursion Pharmaceuticals, Inc..

Financial health

Review financial health context for Recursion Pharmaceuticals, Inc..

Dividend

Review dividend context for Recursion Pharmaceuticals, Inc..

Management

Review management context for Recursion Pharmaceuticals, Inc..

Ownership

Review ownership context for Recursion Pharmaceuticals, Inc..

Other information

Review other information context for Recursion Pharmaceuticals, Inc..

Community

Review community context for Recursion Pharmaceuticals, Inc..